S. Nishimura

发表

Partial volume effect-corrected FDG PET and grey matter volume loss in patients with mild Alzheimer’s disease

H. Matsuda, I. Matsunari, M. Samuraki, 2007, European Journal of Nuclear Medicine and Molecular Imaging.

Effect of sample size for normal database on diagnostic performance of brain FDG PET for the detection of Alzheimer's disease using automated image analysis

I. Matsunari, M. Yoshita, K. Ono, 2008, Nuclear medicine communications.

Bacterial degradation and reduction in the estrogen activity of 4-nonylphenol.

S. Nishimura, J. Sawai, M. Kikuchi, 2012, Biocontrol science.

Synthesis and evaluation of [11C]FR194921 as a nonxanthine-type PET tracer for adenosine A1 receptors in the brain.

S. Nishimura, T. Matsuya, H. Takamatsu, 2005, Nuclear medicine and biology.

Rapid scanning protocol for brain (18)F-FDG PET: a validation study.

S. Minoshima, I. Matsunari, D. Yanase, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Diclofenac, a non-steroidal anti-inflammatory drug, suppresses apoptosis induced by endoplasmic reticulum stresses by inhibiting caspase signaling

S. Nishimura, T. Yamazaki, O. Okitsu, 2006, Neuropharmacology.

PET measurement of FK506 concentration in a monkey model of stroke.

S. Nishimura, H. Takamatsu, Y. Murakami, 2007, Nuclear medicine and biology.

Inhibition of oligopeptide transporter suppress growth of human pancreatic cancer cells.

Y. Kato, A. Tsuji, S. Nishimura, 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Molecular analysis of antilipemic effects of FR218944, a novel vasopressin V1a receptor antagonist, in genetically diabetic db/db mice in comparison with pioglitazone and fenofibrate

S. Nishimura, M. Morita, A. Nagashima, 2003 .

Characterization of a novel thrombotic middle cerebral artery occlusion model in monkeys that exhibits progressive hypoperfusion and robust cortical infarction

Y. Furuichi, S. Nishimura, N. Matsuoka, 2005, Journal of Neuroscience Methods.

Ultra-rapid synthesis of 15O-labeled 2-deoxy-D-glucose for positron emission tomography (PET).

E. Nakamura, S. Nishimura, H. Yorimitsu, 2005, Angewandte Chemie.

Time courses of progress to the chronic stage of middle cerebral artery occlusion models in rats

S. Nishimura, K. Umemura, Satoshi Nitta, 2002, Experimental Brain Research.

Detailed in vitro pharmacological analysis of FK506-induced neuroprotection

S. Nishimura, T. Yamazaki, M. Muramoto, 2003, Neuropharmacology.

Drug Discovery for PTSD: Characterization of an Animal Model of PTSD and PET Imaging of Brain Glucocorticoid Receptor

T. Yamaji, S. Nishimura, N. Matsuoka, 2006 .

Cancer Detection Using a PET Tracer, 11C-Glycylsarcosine, Targeted to H+/Peptide Transporter

Y. Kato, A. Tsuji, Yukio Nakamura, 2008, Journal of Nuclear Medicine.

Pharmacokinetic animal PET study of FK506 as a potent neuroprotective agent.

S. Nishimura, K. Tabata, T. Sawamoto, 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Protective effect of FK506 against apoptosis of SH-SY5Y cells correlates with regulation of the serum inducible kinase gene.

S. Nishimura, T. Yamazaki, O. Okitsu, 2005, Biochemical pharmacology.

Macaque brain PET study on [11C]ASP0777, an non-competitive NMDA receptor antagonist

S. Nishimura, S. Miyoshi, Y. Murakami, 2014 .

Rapid synthesis of 11C-labeled FK506 for positron emission tomography

S. Nishimura, A. Kuroda, Y. Murakami, 2003 .

The evolutionarily conserved G protein-coupled receptor SREB2/GPR85 influences brain size, behavior, and vulnerability to schizophrenia

A. Meyer-Lindenberg, R. Straub, M. Egan, 2008, Proceedings of the National Academy of Sciences.

Measurement of brain concentration of FK960 for development of a novel antidementia drug: a PET study in conscious rhesus monkeys.

K. Yajima, S. Nishimura, H. Takamatsu, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Synthesis of 18F labelled FK960, a candidate anti‐dementia drug, and PET studies in conscious monkeys

N. Harada, H. Tsukada, S. Nishimura, 2002 .

A PET study following treatment with a pharmacological stressor, FG7142, in conscious rhesus monkeys

S. Nishimura, A. Kurumaji, H. Takamatsu, 2003, Brain Research.

Differences in gene expression profile among SH‐SY5Y neuroblastoma subclones with different neurite outgrowth responses to nerve growth factor

Yoshiki Katayama, Shintaro Nishimura, Toshiaki Aoki, 2005, Journal of neurochemistry.

A new method for N-demethylation of 2-deoxy-2-methylamino-α-d-glucopyranoside derivatives by air oxidation using palladium in aqueous 1,4-dioxane

S. Nishimura, S. Umezawa, T. Tsuchiya, 1983 .

Evaluation of human peroxisome proliferator-activated receptor (PPAR) subtype selectivity of a variety of anti-inflammatory drugs based on a novel assay for PPAR delta(beta).

T. Fujimura, S. Nishimura, I. Aramori, 2003, Journal of pharmacological sciences.

Molecular cloning and characterization of two novel human RXRα splice variants

T. Isogai, S. Nishimura, H. Kojo, 2004, The Journal of Steroid Biochemistry and Molecular Biology.

Radiosynthesis, biodistribution and imaging of [11C]YM155, a novel survivin suppressant, in a human prostate tumor-xenograft mouse model.

S. Nishimura, S. Miyoshi, K. Yamanaka, 2013, Nuclear medicine and biology.

18F-labelled annexin V: a PET tracer for apoptosis imaging

Akihiro Noda, Shintaro Nishimura, Junichi Taki, 2004, European Journal of Nuclear Medicine and Molecular Imaging.

Identification of a selective ERK inhibitor and structural determination of the inhibitor-ERK2 complex.

T. Kinoshita, S. Nishimura, M. Neya, 2005, Biochemical and biophysical research communications.

Suppressive effects of FR167653, an inhibitor of p38 mitogen-activated kinase, on calreticulin mRNA expression induced by endoplasmic reticulum stresses.

S. Nishimura, T. Yamazaki, M. Muramoto, 2004, European journal of pharmacology.

Radioisotopes in Drug Research and Development: Focus on Positron Emission Tomography

S. Veltkamp, S. Nishimura, S. Miyoshi, 2011 .

Effect of N-(4-Acetyl-1-piperazinyl)-p-fluorobenzamide Monohydrate (FK960), an Antidementia Drug with a Novel Mechanism of Action, on Regional Cerebral Blood Flow and Glucose Metabolism in Aged Rhesus Macaques Studied with Positron Emission Tomography

H. Tsukada, S. Nishimura, N. Matsuoka, 2003, Journal of Pharmacology and Experimental Therapeutics.

A novel estrogen receptor-related protein γ splice variant lacking a DNA binding domain exon modulates transcriptional activity of a moderate range of nuclear receptors

T. Isogai, S. Nishimura, H. Kojo, 2006, The Journal of Steroid Biochemistry and Molecular Biology.

FK506 attenuates early ischemic neuronal death in a monkey model of stroke.

T. Kakiuchi, H. Tsukada, S. Nishimura, 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Brain penetration of telmisartan, a unique centrally acting angiotensin II type 1 receptor blocker, studied by PET in conscious rhesus macaques.

S. Nishimura, S. Miyoshi, H. Fushiki, 2012, Nuclear medicine and biology.

Evaluation of the kappa-opioid receptor-selective tracer [11C]GR103545 in awake rhesus macaques

Frode Willoch, Trine Hjornevik, Erik Årstad, 2010, European Journal of Nuclear Medicine and Molecular Imaging.

Pre-clinical validation of orthotopically-implanted pulmonary tumor by imaging with 18F-fluorothymidine-positron emission tomography/computed tomography.

I. Matsunari, S. Nishimura, S. Miyoshi, 2013, Anticancer research.

Donepezil- and scopolamine-induced rCMRglu changes assessed by PET in conscious rhesus monkeys

Makoto Asai, Akihiro Noda, Shintaro Nishimura, 2009, Annals of nuclear medicine.

CyclinB2 and BIRC5 genes as surrogate biomarkers for neurite outgrowth in SH-SY5Y subclonal cells

T. Aoki, S. Nishimura, T. Yamazaki, 2006, Neuropharmacology.

Effect of an age-mismatched and sex-mismatched normal database on the diagnostic performance of 18F-FDG PET for Alzheimer’s disease: The Ishikawa Brain Imaging Study

I. Matsunari, M. Yoshita, K. Ono, 2011, Nuclear medicine communications.

Brain FDG PET study of normal aging in Japanese: effect of atrophy correction

Kazuyoshi Yajima, Hiroshi Matsuda, Daisuke Yanase, 2005, European Journal of Nuclear Medicine and Molecular Imaging.

Nuclear receptor errϝ3

T. Isogai, S. Nishimura, H. Kojo, 2003 .

An epoch-making application of discharge plasma phenomenon to gene-transfer.

S. Nishimura, H. Arakawa, N. Morikawa, 2005, Biotechnology and bioengineering.

Determination of Kinetic Rate Constants for 2-[18F]fluoro-2-deoxy-d-glucose and Partition Coefficient of Water in Conscious Macaques and Alterations in Aging or Anesthesia Examined on Parametric Images with an Anatomic Standardization Technique

Hideo Tsukada, Akihiro Noda, Satoshi Minoshima, 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Hideo Tsukada, Masami Futatsubashi, Hiroyuki Ohba, 2002, Brain Research.

Synthesis and bioimaging of positron-emitting 15O-labeled 2-deoxy-D-glucose of two-minute half-life.

Eiichi Nakamura, Shintaro Nishimura, E. Nakamura, 2007, Chemistry, an Asian journal.

Brain Adenosine A2A Receptor Occupancy by a Novel A1/A2A Receptor Antagonist, ASP5854, in Rhesus Monkeys: Relationship to Anticataleptic Effect

A. Iwashita, S. Nishimura, S. Miyoshi, 2008, Journal of Nuclear Medicine.

Amyloid imaging in aged and young macaques with [11C]PIB and [18F]FDDNP

Hideo Tsukada, Akihiro Noda, Shingo Nishiyama, 2008, Synapse.

Short Communication Amyloid Imaging in Aged and Young Macaques With ( 11 C)PIB and ( 18 F)FDDNP

S. Nishiyama, H. Tsukada, D. Fukumoto, 2008 .

Synergistic effects of adenosine A2A antagonist and L-DOPA on rotational behaviors in 6-hydroxydopamine-induced hemi-Parkinsonian mouse model.

M. Asai, H. Mizoguchi, T. Nagai, 2007, Journal of pharmacological sciences.

FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel potential antidementia drug, restores the regional cerebral blood flow response abolished by scopolamine but not by HA-966: a positron emission tomography study with unanesthetized rhesus monkeys

S. Nishiyama, T. Kakiuchi, H. Tsukada, 1999, Brain Research.

Three-dimensional stereotactic surface projection analysis of macaque brain PET: development and initial applications.

D E Kuhl, S Minoshima, D. Kuhl, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

suppressant, in a human prostate tumor-xenograft mouse model

S. Nishimura, S. Miyoshi, K. Yamanaka, 2013 .

Synthesis and evaluation of [11C]RU40555, a selective glucocorticoid receptor antagonist

S. Nishimura, T. Matsuya, H. Takamatsu, 2005 .

An application of a new planar positron imaging system (PPIS) in a small animal: MPTP-induced Parkinsonism in mouse

Hiroshi Uchida, Hideo Tsukada, Akihiro Noda, 2004, Annals of nuclear medicine.

A PET study after treatment with an anxiety-provoking agent, m-chlorophenyl-piperazine, in conscious rhesus monkeys.

S. Nishimura, H. Takamatsu, Y. Murakami, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Discovery of novel inhibitors of inducible nitric oxide synthase

A. Fujikawa, S. Nishimura, Y. Notsu, 2002, The Journal of pharmacy and pharmacology.

[Consideration on molecular imaging technology as a tool for drug research and development].

Kazuyoshi Yajima, Shintaro Nishimura, K. Yajima, 2009, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Effects of non-steroidal anti-inflammatory drugs on Aβ deposition in Aβ1–42 transgenic C. elegans

S. Nishimura, M. Morita, N. Matsuoka, 2009, Brain Research.

Brain Adenosine A2A Receptor Occupancy by a Novel A1/A2A Receptor Antagonist, ASP5854, in Rhesus Monkeys: Relationship to Anticataleptic Effect

A. Iwashita, S. Nishimura, S. Miyoshi, 2008, Journal of Nuclear Medicine.

Structure of a high-resolution crystal form of human triosephosphate isomerase: improvement of crystals using the gel-tube method.

Hidenori Nakajima, Takayoshi Kinoshita, Shintaro Nishimura, 2005, Acta crystallographica. Section F, Structural biology and crystallization communications.